HHSE MERGER Disclosure Bullet Points Summary
Post# of 7290
(Total Views: 423)
Posted On: 04/10/2017 1:22:42 AM
HHSE MERGER Disclosure Bullet Points Summary
* HHSE and another fully registered public equity.
* Mutually executed a letter of intent agreement for a corporate merger
* Significant impact to the financial strength, operations, profile and activities of HHSE
* Contemplated as a stock-for-stock swap
* Hannover House, Inc. shareholders collectively maintaining a majority stock interest and control
* INITIAL (might be more) $65-mm in production and distribution financing arranged for by the merger partner.
* Both partners anticipate that the merger shall become effective following certain regulatory compliances and the remittance of specified payments to Company – both of which events are anticipated to be resolved on or before April 14, 2017.
* Immediate and significant premium value to HHSE shareholders
* Position the Company to fill the currently open market niche’ for a domestic studio focusing on high-quality, mid-level theatrical features (with movies of the budgetary cost and commercial appeal such as “Get Out”, “Little Miss Sunshine”, “Lion” – e.g., quality independent films with budgets of $3-mm to $7-mm and USA box office values approaching $100-mm)
* Merger currently under review and is anticipated to be resolved on or before April 14, 2017
* Upon Merger Closure, Company shall be a fully registered, fully reporting equity, with DTC approved stock trading and the opportunity to quickly uplist to NASDAQ
HHSE 10-K Annual Report (Page 22) - 3/31/17:
https://www.otcmarkets.com/ajax/showFinancial...?id=168732
* HHSE and another fully registered public equity.
* Mutually executed a letter of intent agreement for a corporate merger
* Significant impact to the financial strength, operations, profile and activities of HHSE
* Contemplated as a stock-for-stock swap
* Hannover House, Inc. shareholders collectively maintaining a majority stock interest and control
* INITIAL (might be more) $65-mm in production and distribution financing arranged for by the merger partner.
* Both partners anticipate that the merger shall become effective following certain regulatory compliances and the remittance of specified payments to Company – both of which events are anticipated to be resolved on or before April 14, 2017.
* Immediate and significant premium value to HHSE shareholders
* Position the Company to fill the currently open market niche’ for a domestic studio focusing on high-quality, mid-level theatrical features (with movies of the budgetary cost and commercial appeal such as “Get Out”, “Little Miss Sunshine”, “Lion” – e.g., quality independent films with budgets of $3-mm to $7-mm and USA box office values approaching $100-mm)
* Merger currently under review and is anticipated to be resolved on or before April 14, 2017
* Upon Merger Closure, Company shall be a fully registered, fully reporting equity, with DTC approved stock trading and the opportunity to quickly uplist to NASDAQ
HHSE 10-K Annual Report (Page 22) - 3/31/17:
https://www.otcmarkets.com/ajax/showFinancial...?id=168732
(2)
(0)Hannover House Inc. (HHSE) Stock Research Links
Scroll down for more posts ▼